The US FDA has issued a nationwide alert warning consumers not to use Liqiang 4 Dietary Supplement Capsules

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1495, 2005-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tiratricol warning issued by US FDA

By  

Inpharma, Vol. 1, Iss. 1266, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

The US FDA has issued a statement on the use of conjugated estrogens/medroxyprogesterone

By  

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

The US FDA has asked Bayer to add a Boxed Warning to the labelling for nimodipine [Nimotop] capsules

By  

Reactions Weekly, Vol. 1, Iss. 1087, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The US FDA is warning of the potential risks associated with the use of some infants' liquid vitamin D supplement products

By  

Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The US FDA has issued a Talk Paper advising of changes to the US Strattera [atomoxetine] labelling

By  

Reactions Weekly, Vol. 1, Iss. 1033, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite